Ardelyx (ARDX) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to loss of $0.31 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 500%. A quarter ago, it was expected that this biotechnology company would post a loss of $0.17 per share when it actually produced a loss of $0.14, delivering a surprise of 17.65%.
I have a full load already from earlier trades. However, I wanted to double that load today. Within seconds of the open, this sucker looked like a rocket on the intraday charts.
